Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Patient Information Fact Sheets
Download or print easy-to-read disease leaflets for your patients.
Industry Supported Education
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
The Food and Drug Administration (FDA) is warning consumers not to buy or use "Feng Shi Ling," a product marketed as an herbal drug for pain due to rheumatoid arthritis and osteoporosis.
Compared to acetaminophen monotherapy, the combination of acetylsalicylic acid, caffeine and acetaminophen is more effective in treating episodic tension-type headaches, says a new study.
The FDA has approved Hysingla ER (hydrocodone bitartrate; Purdue) extended-release tablets for the treatment of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
U.S. national data show steady rise, and abuse may pose dangers to mother and baby.
Featured courses from mycme
Discussing end of life issues and palliative care options with patients who have life-limiting illnesses ...
This course will provide introductory background, knowledge and skills to meet the potential knowledge gap ...
Migraine and other severe headaches are a common and major public health problem. Faculty presentations ...
- Can Wearables for Babies Help Prevent SIDS?
- Most Excessive Drinkers Don't Meet Alcohol Dependence Criteria
- Carcinogen from Hookah Smoke Harmful, Even in Secondhand Exposure
- Refined vs. Extra Virgin Olive Oil: Is One Better for Cardiovascular Health?
- Digoxin and Incident A-Fib: New Results on Mortality, Hospitalization Risk